Biopharmaceuticals Contract Manufacturing Market size was valued at US$ 3.37 Bn in 2023 and the total revenue is expected to grow at 9.19% through 2024 to 2030, reaching nearly US$ 6.24 Bn. The Biopharmaceuticals Contract Manufacturing market report is a comprehensive analysis of the industry, market, and key players. The report has covered the market by demand and supply-side by segments. The global Biopharmaceuticals Contract Manufacturing report also provides trends by market segments, technology, and investment with a competitive landscape.To know about the Research Methodology :- Request Free Sample ReportBiopharmaceuticals Contract Manufacturing Market Overview:
A contract manufacturing organization (CMO) is a corporation that provides specialized services from drug production to drug manufacturing to other organizations in the biopharmaceutical industry on a contract basis. This helps large biopharmaceutical firms to outsource some facets of their operations, which may help with scalability or increase revenues for drug discovery and drug development. Antibodies, non-antibody scaffolds, recombinant proteins, fragments, and DNA are all manufactured by separate biopharmaceutical firms from various sources. The increasing popularity of biologics has resulted in a healthcare paradigm change. The number of biopharmaceutical approvals by the US FDA has gradually increased over the last decade. In particular, the United States authorized a total of 28 biopharmaceutical drugs in 2022 (including monoclonal antibodies, recombinant proteins, and gene therapies). In addition, over 8,000 biological medicinal drugs are currently being tested in clinical trials around the world.Biopharmaceuticals Contract Manufacturing Market Dynamics:
Drivers:
Biopharmaceuticals are a type of medication. In terms of complexity, behavior, manufacture, and how large molecules behave in the human body, large molecules vary from pharmaceutical small molecules. Making such big molecules is a lot more difficult than making conventional pharmaceuticals. Biopharma is, in particular, a highly technological business with complicated processes that only a few players have fully mastered. Biopharmaceutical firms have been gradually increasing in size for many years, and the prevalence of massive pipeline molecules in clinical trials suggests that this trend will continue. More than 235 firms currently have contract production facilities for biopharmaceuticals, handling a wide range of biologics. Proteins/peptides, antibodies, and vaccines are among the most popular resources provided by contract manufacturing organizations (CMOs). Furthermore, mammalian cell-based manufacturing is more common than microbial expression systems, and this pattern is expected to continue in the future. The use of CMOs by major pharmaceutical and biotechnology firms to satisfy variable demand and obtain access to other capabilities is another reason for the industry's continued expansion. Continued market restructuring is another pattern reported by respondents. They also anticipate the entry of new CMOs and the specialization of existing CMOs. Furthermore, strong advances in research and development, new markets, and consolidation in the pharmaceutical CMO industry is expected to boost biopharmaceuticals contract manufacturing growth during the forecast period.Biopharmaceuticals Contract Manufacturing Market Segment Analysis:
Based on Product, the biologics product segment led the industry in 2023, with an 80% of revenue sales even though contract manufacturers were crucial to the growth of both biologics and biosimilars. Due to the enormous commercial success of biologics, as shown by the availability of a vast number of FDA-approved biologics on the market, the category will retain its dominant position over the forecast era. Monoclonal Antibodies (MAb) have the highest market share for biologics in 2023. Due to the high capital requirements for the construction of a MAb factory, contract services for MAb production have accelerated, leading to the segment's expansion. Based on Source, the mammalian root segment dominated the industry in 2023, with a share of over 59 percent. The industry is expected to expand as a result of an extensive investigation into the use of multiple sources and organisms for biopharmaceutical growth. The primary goal of these studies is to improve biopharmaceutical manufacturing competitiveness and performance. Since a large percentage of biopharmaceutical products in development are mammalian-based, the category will continue to lead during the forecast era. From 2024 to 2030, the non-mammalian source segment is expected to grow at the fastest pace. E. coli, a non-mammalian cell line, is the most commonly used non-mammalian cell culture for biopharmaceutical processing due to its ease of access and low cost of cultivation. Based on Service, process automation services dominated the world market with a share of over 33%, in 2023. This is because downstream production needs a lot of money. Furthermore, downstream processes necessitate a high level of focus on final product recovery and purification measures to improve product consistency and avoid waste. CMOs also provided biopharma companies with a wide range of facilities, from cell cultivation to final product packaging. Process production, fill & finish activities, analytical & QC tests, and packaging are among the manufacturing services provided by CMOs. The analytical & QC studies segment is expected to rise at the fastest rate during the forecast period, owing to rising quality issues and regulatory changes for biopharmaceutical growth. To ensure product purity and protection, new regulations are being implemented for CMOs producing biologics following regulatory requirements.Biopharmaceuticals Contract Manufacturing Market Regional Insights:
Because of the large number of biopharmaceutical companies with large production capacities and the high demand for biologics in this region, North America is expected to have a substantial market share in the global biopharmaceuticals contract manufacturing market. Furthermore, the increasing focus on superior biopharmaceutical goods, biosimilars, and biopharmaceutical-based research and development activities accounted for a significant percentage of total research and development activities carried out in different industries, which is fueling the overall regional market growth to a large extent. The market for biopharmaceutical contract manufacturing is expanding, owing to rising biologics demand and increased outsourcing by pharmaceutical firms in the Asia Pacific. In the coming years, increased consolidation in the sector is expected to stifle business growth. The objective of the report is to present a comprehensive analysis of the global Biopharmaceuticals Contract Manufacturing market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the global Biopharmaceuticals Contract Manufacturing market dynamics, structure by analyzing the market segments and project the global Biopharmaceuticals Contract Manufacturing market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the global Biopharmaceuticals Contract Manufacturing market make the report investor’s guide.Biopharmaceuticals Contract Manufacturing Market Scope: Inquire before buying
Biopharmaceuticals Contract Manufacturing Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: US $ 3.37 Bn. Forecast Period 2024 to 2030 CAGR: 9.19% Market Size in 2030: US $ 6.24 Bn. Segments Covered: by Product Biologics Monoclonal Antibodies (MAbs) Recombinant Proteins Vaccines Antisense, RNAi, & Molecular Therapy Biosimilars by Source Mammalian Non-mammalian by Service Process Development Fill & Finish Operations Analytical and QC Studies Packaging Biopharmaceuticals Contract Manufacturing Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe) Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina, Columbia and Rest of South America)Biopharmaceuticals Contract Manufacturing Market, Key Players
1. Boehringer Ingelheim GmbH 2. Lonza 3. Inno Biologics Sdn Bhd 4. Rentschler Biotechnologies GmbH 5. JRS Pharma 6. AGC Biologics 7. ProBioGen 8. Fujifilm Diosynth Biotechnologies U.S.A., Inc. 9. Toyobo Co., Ltd. 10. Samsung BioLogics 11. Thermo Fisher Scientific, Inc. 12. Binex Co., Ltd. 13. WuXi Biologics 14. AbbVie, Inc. 15. Other Key Players Frequently Asked Questions: 1. Which region has the largest share in Global Biopharmaceuticals Contract Manufacturing Market? Ans: North America region held the highest share in 2023. 2. What is the growth rate of Global Biopharmaceuticals Contract Manufacturing Market? Ans: The Global Biopharmaceuticals Contract Manufacturing Market is growing at a CAGR of 9.19% during forecasting period 2024-2030. 3. What is scope of the Global Biopharmaceuticals Contract Manufacturing Market report? Ans: Global Biopharmaceuticals Contract Manufacturing Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Biopharmaceuticals Contract Manufacturing Market? Ans: The important key players in the Global Biopharmaceuticals Contract Manufacturing Market are – Boehringer Ingelheim GmbH, Lonza, Inno Biologics Sdn Bhd, Rentschler Biotechnologies GmbH, JRS Pharma, AGC Biologics, ProBioGen, Fujifilm Diosynth Biotechnologies U.S.A., Inc., Toyobo Co., Ltd., Samsung BioLogics, Thermo Fisher Scientific, Inc., Binex Co., Ltd., WuXi Biologics, AbbVie, Inc., Other Key Players. 5. What is the study period of this Market? Ans: The Global Biopharmaceuticals Contract Manufacturing Market is studied from 2023 to 2030.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Biopharmaceuticals Contract Manufacturing Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2023 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Biopharmaceuticals Contract Manufacturing Market 3.4. Geographical Snapshot of the Biopharmaceuticals Contract Manufacturing Market, By Manufacturer share 4. Global Biopharmaceuticals Contract Manufacturing Market Overview, 2023-2030 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Biopharmaceuticals Contract Manufacturing Market 5. Supply Side and Demand Side Indicators 6. Global Biopharmaceuticals Contract Manufacturing Market Analysis and Forecast, 2023-2030 6.1. Global Biopharmaceuticals Contract Manufacturing Market Size & Y-o-Y Growth Analysis. 7. Global Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2023-2030 7.1. Market Size (Value) Estimates & Forecast By Product, 2023-2030 7.1.1. Biologics 7.1.1.1. Monoclonal Antibodies (MAbs) 7.1.1.2. Recombinant Proteins 7.1.1.3. Vaccines 7.1.1.4. Antisense, RNAi, & Molecular Therapy 7.1.2. Biosimilars 7.2. Market Size (Value) Estimates & Forecast By Source, 2023-2030 7.2.1. Mammalian 7.2.2. Non-mammalian 7.3. Market Size (Value) Estimates & Forecast By Service, 2023-2030 7.3.1. Process Development 7.3.2. Fill & Finish Operations 7.3.3. Analytical and QC Studies 7.3.4. Packaging 8. Global Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2023-2030 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2023-2030 9.1. Market Size (Value) Estimates & Forecast By Product, 2023-2030 9.1.1. Biologics 9.1.1.1. Monoclonal Antibodies (MAbs) 9.1.1.2. Recombinant Proteins 9.1.1.3. Vaccines 9.1.1.4. Antisense, RNAi, & Molecular Therapy 9.1.2. Biosimilars 9.2. Market Size (Value) Estimates & Forecast By Source, 2023-2030 9.2.1. Mammalian 9.2.2. Non-mammalian 9.3. Market Size (Value) Estimates & Forecast By Service, 2023-2030 9.3.1. Process Development 9.3.1.1. Downstream 9.3.1.2. Upstream 9.3.2. Fill & Finish Operations 9.3.3. Analytical and QC Studies 9.3.4. Packaging 10. North America Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2023-2030 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2023-2030 11.1. Market Size (Value) Estimates & Forecast By Product, 2023-2030 11.2. Market Size (Value) Estimates & Forecast By Source, 2023-2030 11.3. Market Size (Value) Estimates & Forecast By Service, 2023-2030 12. Canada Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2023-2030 12.1. Market Size (Value) Estimates & Forecast By Product, 2023-2030 12.2. Market Size (Value) Estimates & Forecast By Source, 2023-2030 12.3. Market Size (Value) Estimates & Forecast By Service, 2023-2030 13. Mexico Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2023-2030 13.1. Market Size (Value) Estimates & Forecast By Product, 2023-2030 13.2. Market Size (Value) Estimates & Forecast By Source, 2023-2030 13.3. Market Size (Value) Estimates & Forecast By Service, 2023-2030 14. Europe Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2023-2030 14.1. Market Size (Value) Estimates & Forecast By Product, 2023-2030 14.2. Market Size (Value) Estimates & Forecast By Source, 2023-2030 14.3. Market Size (Value) Estimates & Forecast By Service, 2023-2030 15. Europe Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2023-2030 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2023-2030 16.1. Market Size (Value) Estimates & Forecast By Product, 2023-2030 16.2. Market Size (Value) Estimates & Forecast By Source, 2023-2030 16.3. Market Size (Value) Estimates & Forecast By Service, 2023-2030 17. France Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2023-2030 17.1. Market Size (Value) Estimates & Forecast By Product, 2023-2030 17.2. Market Size (Value) Estimates & Forecast By Source, 2023-2030 17.3. Market Size (Value) Estimates & Forecast By Service, 2023-2030 18. Germany Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2023-2030 18.1. Market Size (Value) Estimates & Forecast By Product, 2023-2030 18.2. Market Size (Value) Estimates & Forecast By Source, 2023-2030 18.3. Market Size (Value) Estimates & Forecast By Service, 2023-2030 19. Italy Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2023-2030 19.1. Market Size (Value) Estimates & Forecast By Product, 2023-2030 19.2. Market Size (Value) Estimates & Forecast By Source, 2023-2030 19.3. Market Size (Value) Estimates & Forecast By Service, 2023-2030 20. Spain Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2023-2030 20.1. Market Size (Value) Estimates & Forecast By Product, 2023-2030 20.2. Market Size (Value) Estimates & Forecast By Source, 2023-2030 20.3. Market Size (Value) Estimates & Forecast By Service, 2023-2030 21. Sweden Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2023-2030 21.1. Market Size (Value) Estimates & Forecast By Product, 2023-2030 21.2. Market Size (Value) Estimates & Forecast By Source, 2023-2030 21.3. Market Size (Value) Estimates & Forecast By Service, 2023-2030 22. CIS Countries Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2023-2030 22.1. Market Size (Value) Estimates & Forecast By Product, 2023-2030 22.2. Market Size (Value) Estimates & Forecast By Source, 2023-2030 22.3. Market Size (Value) Estimates & Forecast By Service, 2023-2030 23. Rest of Europe Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2023-2030 23.1. Market Size (Value) Estimates & Forecast By Product, 2023-2030 23.2. Market Size (Value) Estimates & Forecast By Source, 2023-2030 23.3. Market Size (Value) Estimates & Forecast By Service, 2023-2030 24. Asia Pacific Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2023-2030 24.1. Market Size (Value) Estimates & Forecast By Product, 2023-2030 24.2. Market Size (Value) Estimates & Forecast By Source, 2023-2030 24.3. Market Size (Value) Estimates & Forecast By Service, 2023-2030 25. Asia Pacific Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2023-2030 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2023-2030 26.1. Market Size (Value) Estimates & Forecast By Product, 2023-2030 26.2. Market Size (Value) Estimates & Forecast By Source, 2023-2030 26.3. Market Size (Value) Estimates & Forecast By Service, 2023-2030 27. India Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2023-2030 27.1. Market Size (Value) Estimates & Forecast By Product, 2023-2030 27.2. Market Size (Value) Estimates & Forecast By Source, 2023-2030 27.3. Market Size (Value) Estimates & Forecast By Service, 2023-2030 28. Japan Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2023-2030 28.1. Market Size (Value) Estimates & Forecast By Product, 2023-2030 28.2. Market Size (Value) Estimates & Forecast By Source, 2023-2030 28.3. Market Size (Value) Estimates & Forecast By Service, 2023-2030 29. South Korea Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2023-2030 29.1. Market Size (Value) Estimates & Forecast By Product, 2023-2030 29.2. Market Size (Value) Estimates & Forecast By Source, 2023-2030 29.3. Market Size (Value) Estimates & Forecast By Service, 2023-2030 30. Australia Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2023-2030 30.1. Market Size (Value) Estimates & Forecast By Product, 2023-2030 30.2. Market Size (Value) Estimates & Forecast By Source, 2023-2030 30.3. Market Size (Value) Estimates & Forecast By Service, 2023-2030 31. ASEAN Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2023-2030 31.1. Market Size (Value) Estimates & Forecast By Product, 2023-2030 31.2. Market Size (Value) Estimates & Forecast By Source, 2023-2030 31.3. Market Size (Value) Estimates & Forecast By Service, 2023-2030 32. Rest of Asia Pacific Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2023-2030 32.1. Market Size (Value) Estimates & Forecast By Product, 2023-2030 32.2. Market Size (Value) Estimates & Forecast By Source, 2023-2030 33. Middle East Africa Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2023-2030 33.1. Market Size (Value) Estimates & Forecast By Product, 2023-2030 33.2. Market Size (Value) Estimates & Forecast By Source, 2023-2030 33.3. Market Size (Value) Estimates & Forecast By Service, 2023-2030 34. Middle East Africa Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2023-2030 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2023-2030 35.1. Market Size (Value) Estimates & Forecast By Product, 2023-2030 35.2. Market Size (Value) Estimates & Forecast By Source, 2023-2030 35.3. Market Size (Value) Estimates & Forecast By Service, 2023-2030 36. GCC Countries Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2023-2030 36.1. Market Size (Value) Estimates & Forecast By Product, 2023-2030 36.2. Market Size (Value) Estimates & Forecast By Source, 2023-2030 36.3. Market Size (Value) Estimates & Forecast By Service, 2023-2030 37. Egypt Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2023-2030 37.1. Market Size (Value) Estimates & Forecast By Product, 2023-2030 37.2. Market Size (Value) Estimates & Forecast By Source, 2023-2030 37.3. Market Size (Value) Estimates & Forecast By Service, 2023-2030 38. Nigeria Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2023-2030 38.1. Market Size (Value) Estimates & Forecast By Product, 2023-2030 38.2. Market Size (Value) Estimates & Forecast By Source, 2023-2030 38.3. Market Size (Value) Estimates & Forecast By Service, 2023-2030 39. Rest of ME&A Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2023-2030 39.1. Market Size (Value) Estimates & Forecast By Product, 2023-2030 39.2. Market Size (Value) Estimates & Forecast By Source, 2023-2030 39.3. Market Size (Value) Estimates & Forecast By Service, 2023-2030 40. South America Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2023-2030 40.1. Market Size (Value) Estimates & Forecast By Product, 2023-2030 40.2. Market Size (Value) Estimates & Forecast By Source, 2023-2030 40.3. Market Size (Value) Estimates & Forecast By Service, 2023-2030 41. South America Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2023-2030 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2023-2030 42.1. Market Size (Value) Estimates & Forecast By Product, 2023-2030 42.2. Market Size (Value) Estimates & Forecast By Source, 2023-2030 42.3. Market Size (Value) Estimates & Forecast By Service, 2023-2030 43. Argentina Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2023-2030 43.1. Market Size (Value) Estimates & Forecast By Product, 2023-2030 43.2. Market Size (Value) Estimates & Forecast By Source, 2023-2030 43.3. Market Size (Value) Estimates & Forecast By Service, 2023-2030 44. Rest of South America Biopharmaceuticals Contract Manufacturing Market Analysis and Forecasts, 2023-2030 44.1. Market Size (Value) Estimates & Forecast By Product, 2023-2030 44.2. Market Size (Value) Estimates & Forecast By Source, 2023-2030 44.3. Market Size (Value) Estimates & Forecast By Service, 2023-2030 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Biopharmaceuticals Contract Manufacturing Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Sources and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Boehringer Ingelheim GmbH 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Lonza 45.3.3. Inno Biologics Sdn Bhd 45.3.4. Rentschler Biotechnologies GmbH 45.3.5. JRS Pharma 45.3.6. AGC Biologics 45.3.7. ProBioGen 45.3.8. Fujifilm Diosynth Biotechnologies U.S.A., Inc. 45.3.9. Toyobo Co., Ltd. 45.3.10. Samsung BioLogics 45.3.11. Thermo Fisher Scientific, Inc. 45.3.12. Binex Co., Ltd. 45.3.13. WuXi Biologics 45.3.14. AbbVie, Inc. 45.3.15. Other Key Players 46. Primary Key Insights